✦ LIBER ✦

Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the controlled abciximab and device investigation to lower late angioplasty complications (cadillac) trial

✍ Scribed by Eugenia Nikolsky; Eve D. Aymong; Amir Halkin; Cindy L. Grines; David A. Cox; Eulogio Garcia; Roxana Mehran; James E. Tcheng; John J. Griffin; Giulio Guagliumi; Thomas Stuckey; Mark Turco; David A. Cohen; Manuela Negoita; Alexandra J. Lansky; Gregg W. Stone

Book ID: 119264194
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 121 KB
Volume: 44
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2004.03.080

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of anemia in patients with acute

Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: Analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial

✍ E. Nikolsky; E.D. Aymong; A. Halkin 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Benefits and risks of abciximab use in p

Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial

✍ J.E. Tcheng; D.E. Kandzari; C.L. Grines 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Importance of mitral regurgitation inpat

Importance of mitral regurgitation inpatients undergoing percutaneous coronaryintervention for acute myocardial infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial

✍ Gregory G. Pellizzon; Cindy L. Grines; David A. Cox; Thomas Stuckey; James E. Tc 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Cost-effectiveness of coronary stenting

Cost-effectiveness of coronary stenting and abciximab for patients with acute myocardial infarction: results from the cadillac (controlled abciximab and device investigation to lower late angioplasty complications) trial

✍ A. Bakhai; G.W. Stone; C.L. Grines 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Gender Differences in Outcomes After Pri

Gender Differences in Outcomes After Primary Angioplasty Versus Primary Stenting With and Without Abciximab for Acute Myocardial Infarction: Results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial

✍ A.J. Lansky; C. Piedras; R.A. Costa 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Prognostic utility of comparative method

Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: The controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial

✍ Michael G. McLaughlin; Gregg W. Stone; Eve Aymong; Graham Gardner; Roxana Mehran 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 176 KB